绥美凯治疗艾滋病的效果如何？

How effective is Inbec in treating AIDS? Let’s find out together. Inbec is a drug for the treatment of AIDS. Inbec is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.

Inbec needs to be taken by adults and teenagers over 12 years old, and their weight is not less than 40kg. Because Inbec is a fixed-dose tablet, the dose cannot be reduced. If the adult or adolescent weighs less than 40kg, Inbec should not be given.

Inbec has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. From the comparison with patients who failed the first-line treatment of the other two integrase inhibitors RAL (Ascent) and EVG (elvitegravir), Inbec (Inbec) has significantly fewer resistance mutation sites than the other two drugs, making it less likely to develop resistance.

Inbec is a drug with DTG, an integrase inhibitor, as its core drug. In the real world, antiviral therapy-naïve patients treated with DTG are more effective than RAL (Ascent), DRV/r (darunavir), and EFV (Etaton). The four drugs (Fiverenz) and ATV/r (Atazanavir) also have a lower proportion of central nervous system-related (CNS) adverse events. Therefore, the drug safety of Trimeq, which is based on DTG integrase inhibitors, has proven to be controllable.

Clinical safety data for Inbec are limited. The most commonly reported adverse reactions thought to be possibly or probably related to dolutegravir and abacavir/lamivudine (pooled data from 679 antiretroviral-naïve subjects who received this combination in phase IIb to IIIb clinical trials) were nausea (12%), insomnia (7%), dizziness (6%), and headache (6%).

Inbec is effective in treating AIDS and is the best choice for many AIDS patients.